Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by scarlet1967on Mar 31, 2021 8:56am

144 Views

Post# 32912679

Short interest/volume

Thera’s short interest is down both in TSX and Nasdaq and the short volume is slightly down from last week’s level, looking at a couple of other Canadian companies TH’s short volume is in the same range as APHA and well below CYDY.

Of course both other companies have higher short interest.

The point is although it’s good to check these numbers periodically and TH is not doing too bad on that front the long term net effect of these trades is insignificant especially in case of TH and this is part of criteria for companies with high daily volume so one has to take the bad with the good.

arket Date	Short Volume	Total Volume (MM Shares)	Short Volume Ratio
2021-03-30	36,169	0.15	23.53
2021-03-29	57,638	0.26	21.81
2021-03-26	59,267	0.30	19.59
2021-03-25	31,060	0.21	14.74
2021-03-24	72,379	0.31	23.06
2021-03-23	103,798	0.44	23.76
2021-03-22	331,762	1.06	31.19
2021-03-19	228,714	0.69	33.01
2021-03-18	77,757	0.42	18.38
2021-03-17	46,398	0.20	22.79

TH

Date	Short Volume	Total Volume (MM Shares)	Short Volume Ratio
2021-03-30	4,437,711	9.71	45.69
2021-03-29	1,261,220	2.94	42.94
2021-03-26	825,753	1.80	45.80
2021-03-25	743,316	2.72	27.29
2021-03-24	714,129	1.95	36.65
2021-03-23	1,130,143	2.36	47.98
2021-03-22	593,362	1.89	31.37
2021-03-19	658,373	1.80	36.61
2021-03-18	568,096	1.95	29.20
2021-03-17	794,387	2.32	34.21

CYDY

Market Date	Short Volume	Total Volume (MM Shares)	Short Volume Ratio
2021-03-30	1,406,239	7.42	18.95
2021-03-29	1,240,681	8.29	14.96
2021-03-26	2,386,142	11.42	20.90
2021-03-25	1,480,055	12.09	12.24
2021-03-24	2,735,779	13.60	20.11
2021-03-23	3,379,859	15.47	21.85
2021-03-22	2,359,371	11.35	20.78
2021-03-19	2,567,028	11.13	23.07
2021-03-18	1,389,907	12.21	11.38
2021-03-17	2,052,543	11.21	18.31